RXST Analyst Ratings
RxSight, Inc. (RXST) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $187.5M, listed on NASDAQ, employing roughly 461 people, carrying a beta of 1.14 to the broader market. As a medical technology enterprise, RxSight, Inc. Led by Aziz Mottiwala, public since 2021-07-30.
Analyst Ratings
In the October 2026 monthly count, 10 analysts rated RXST: 1 Strong Buy, 0 Buy, 7 Hold, 0 Sell and 2 Strong Sell.
Twelve months earlier, in October 2025: 11 analysts, 1 Strong Buy, 0 Buy, 8 Hold, 0 Sell and 2 Strong Sell.
Price Targets
- Average Target
- $7.31
- Median Target
- $6.38
- High
- $11.00
- Low
- $5.50
- Targets Published, Last 12 Months
- 10
Recent Price Targets
The 5 most recent of 10 price targets published in the last 12 months.
| Date | Firm | Analyst | Target | Price When Posted |
|---|---|---|---|---|
| Sep 22, 2026 | Jefferies | Not named | $5.75 | $5.08 |
| Aug 10, 2026 | Stifel Nicolaus | Not named | $7.00 | $6.26 |
| Jul 28, 2026 | UBS | Not named | $5.50 | $5.94 |
| Jul 7, 2026 | Jefferies | Not named | $6.50 | $5.62 |
| May 7, 2026 | Needham | Not named | $11.00 | $6.03 |
Recent Upgrades & Downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 22, 2026 | B of A Securities | maintain | Underperform | Underperform |
| Sep 22, 2026 | Jefferies | maintain | Hold | Hold |
| Aug 10, 2026 | Stifel | maintain | Hold | Hold |
| Aug 6, 2026 | UBS | maintain | Neutral | Neutral |
| Jul 7, 2026 | Needham | maintain | Buy | Buy |
Quantitative Rating
RXST carries a model grade of C (overall score 2 of 5), computed from six valuation and financial measures (discounted cash flow, return on equity, return on assets, debt to equity, price to earnings and price to book), each scored 1 to 5. It is not an analyst rating.
How to Read RXST Analyst Coverage
Sell-side equity analysts publish three primary outputs: ratings (Strong Buy / Buy / Hold / Sell / Strong Sell, or firm-specific equivalents), price targets, and EPS / revenue estimate revisions. Rating consensus moves slowly relative to price; it reflects 12-month directional conviction rather than near-term momentum. Price targets are more responsive but typically drift behind realized price during sharp moves. The most actionable signal for options traders is a cluster of ratings actions across multiple firms within a short window, which compresses or expands implied volatility on a horizon of days to weeks and shifts the put-call skew toward the directional consensus. The recent-actions table above shows the five most recent firm-level changes; longer histories live behind aggregator sources.
For event-driven options sizing, pair the consensus rating and target distribution with the implied-volatility surface and dealer-positioning view. Aggressive target hikes from multiple firms tend to tighten put skew (downside protection becomes relatively cheaper); aggressive cuts widen put skew. The size of the IV response in the hours after a rating change is visible on the per-ticker volatility skew page and the gamma-exposure page, both of which show how dealer hedging propagates the analyst-driven flow into the listed options chain.
Learn how analyst ratings is reported and how to read the data →
Frequently asked RXST analyst ratings questions
- What is the RXST consensus price target?
- As of the latest aggregator update, RxSight, Inc. (RXST) carries a consensus 12-month price target of $7.31. Target ranges run from a low of $5.50 to a high of $11.00. The target is the average of the price targets published by sell-side equity analysts covering the name.
- What is the analyst rating consensus on RXST?
- In the October 2026 monthly count, 10 analysts rated RXST, and the distribution is concentrated at Hold: 1 Strong Buy, 0 Buy, 7 Hold, 0 Sell and 2 Strong Sell. Rating consensus moves slowly relative to price; it reflects sell-side conviction over a 12-month horizon rather than near-term momentum.
- What recent ratings actions has RXST seen?
- The five most recent ratings actions on RXST appear on the page above. Sell-side rating changes are watched for two reasons: an upgrade or downgrade with a meaningful target revision moves the consensus and can trigger short-term positioning shifts, and the firm-level rating cluster (multiple firms moving in the same direction within a short window) is a clearer signal than any single action. Options markets often price the implied-vol response within minutes of the announcement.
- How do analyst targets affect RXST options pricing?
- Analyst target revisions tend to be priced in by the lit options market within minutes of publication, but persistent target drift over weeks does correlate with implied-volatility movement. Aggressive target hikes from multiple firms inside a single quarter tighten put skew (downside protection becomes cheaper relative to upside speculation); aggressive cuts widen put skew. The most actionable read is the implied-vol response in the hours after a target change, which is visible on the per-ticker volatility skew page.